LO FRANCIS

CIK 00017806601 companySEATTLE, WA

SEC Profile

Transactions

Companies

Filings

CIK

0001780660

Recent Transactions

50 trades

Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Stock Option (right to buy)
2026-01-12−36,650→ 75,500 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Stock Option (right to buy)
2026-01-12−21,002→ 87,074 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Stock Option (right to buy)
2026-01-12−7,723→ 177,615 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2026-01-12$17.73/sh−79,590→ 315,978 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Common Stock
2026-01-12$7.80/sh+36,650→ 352,628 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Common Stock
2026-01-12$12.14/sh+7,723→ 360,351 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Common Stock
2026-01-12$8.46/sh+21,002→ 381,353 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Common Stock
2026-01-12$3.99/sh+14,215→ 395,568 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Stock Option (right to buy)
2026-01-12−14,215→ 90,641 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2026-01-02$16.08/sh−3,125→ 315,978 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Common Stock
2026-01-02$3.99/sh+3,125→ 319,103 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Stock Option (right to buy)
2026-01-02−3,125→ 104,856 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Stock Option (right to buy)
2025-12-22−1,100→ 112,150 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Common Stock
2025-12-22$3.99/sh+2,194→ 320,372 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Common Stock
2025-12-22$7.80/sh+1,100→ 317,078 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Common Stock
2025-12-22$8.46/sh+1,100→ 318,178 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Stock Option (right to buy)
2025-12-22−2,194→ 107,981 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Stock Option (right to buy)
2025-12-22−1,100→ 108,076 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2025-12-22$17.50/sh−4,394→ 315,978 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Stock Option (right to buy)
2025-12-15−39,849→ 110,175 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Stock Option (right to buy)
2025-12-15−19,423→ 109,176 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Common Stock
2025-12-15$3.99/sh+39,849→ 429,868 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Stock Option (right to buy)
2025-12-15−37,750→ 113,250 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2025-12-15$15.57/sh−113,890→ 315,978 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Common Stock
2025-12-15$7.80/sh+37,750→ 370,596 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Common Stock
2025-12-15$8.46/sh+19,423→ 390,019 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2025-03-05$6.99/sh−13,790→ 332,846 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2025-03-05$6.98/sh−7,085→ 346,636 total
Award
Adaptive Biotechnologies Corp$ADPT
Common Stock
2025-03-04+99,976→ 353,721 total
Award
Adaptive Biotechnologies Corp$ADPT
Stock Option (right to buy)
2025-03-04+150,024→ 150,024 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2024-03-05$3.43/sh−12,887→ 255,558 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2024-03-05$3.44/sh−1,813→ 253,745 total
Award
Adaptive Biotechnologies Corp$ADPT
Common Stock
2024-03-04+99,976→ 268,445 total
Award
Adaptive Biotechnologies Corp$ADPT
Stock Option (right to buy)
2024-03-04+150,024→ 150,024 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2023-03-06$8.57/sh−6,816→ 168,469 total
Award
Adaptive Biotechnologies Corp$ADPT
Common Stock
2023-03-06+85,697→ 175,285 total
Award
Adaptive Biotechnologies Corp$ADPT
Stock Option (right to buy)
2023-03-06+128,599→ 128,599 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2022-03-08$11.44/sh−3,582→ 89,588 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2022-03-07$12.01/sh−1,569→ 93,170 total
Award
Adaptive Biotechnologies Corp$ADPT
Stock Option (Right to Buy)
2022-03-04+185,338→ 185,338 total
Award
Adaptive Biotechnologies Corp$ADPT
Common Stock
2022-03-04+74,135→ 94,739 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Stock Option (Right To Buy)
2021-05-14−2,000→ 151,000 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Common Stock
2021-05-14$7.80/sh+2,000→ 22,604 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2021-05-14$33.80/sh−2,000→ 20,604 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2021-04-15$43.04/sh−2,000→ 20,604 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Common Stock
2021-04-15$7.80/sh+2,000→ 22,604 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Stock Option (Right To Buy)
2021-04-15−2,000→ 153,000 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2021-03-15$42.03/sh−1,122→ 20,604 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Stock Option (Right To Buy)
2021-03-15−2,000→ 155,000 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2021-03-15$41.57/sh−878→ 21,726 total

Companies

Adaptive Biotechnologies Corp
Chief People Officer
$ADPT

Recent Filings

Address

C/O ADAPTIVE BIOTECHNOLOGIES CORPORATION 1165 EASTLAKE AVE E

SEATTLE, WA, 98109

View on SEC.gov